A Safety and Effectiveness Study of a New Contact Lens Cleaning and Disinfecting Solution
Not Applicable
Completed
- Conditions
- Contact Lens Wear
- Interventions
- Device: NNR06Device: Complete MPS
- First Posted Date
- 2016-03-08
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 396
- Registration Number
- NCT02701556
- Locations
- 🇺🇸
Kannarr EyeCare, Pittsburg, Kansas, United States
Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOL
Completed
- Conditions
- Cataract
- Interventions
- Device: Trulign™ Toric IOL
- First Posted Date
- 2015-03-20
- Last Posted Date
- 2019-11-13
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 600
- Registration Number
- NCT02394379
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States
Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris
Phase 4
Completed
- Conditions
- Tinea CrurisTinea Pedis
- Interventions
- First Posted Date
- 2015-03-20
- Last Posted Date
- 2019-11-27
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 20
- Registration Number
- NCT02394340
- Locations
- 🇺🇸
TKL Research, Fair Lawn, New Jersey, United States
Study to Evaluate the Product Performance of a New Silicone Hydrogel Contact Lens
Not Applicable
Completed
- Conditions
- Corneal Deformity
- Interventions
- Device: B&L Investigational Contact Lens
- First Posted Date
- 2014-10-07
- Last Posted Date
- 2020-09-14
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 38
- Registration Number
- NCT02258139
- Locations
- 🇺🇸
Indiana University, Bloomington, Indiana, United States
Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Phase 3
Completed
- Conditions
- InflammationPainCataract
- Interventions
- Drug: Vehicle Gel (BID)
- First Posted Date
- 2014-08-05
- Last Posted Date
- 2020-09-25
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 326
- Registration Number
- NCT02208297
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Bridgewater, New Jersey, United States
Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.
- First Posted Date
- 2014-01-20
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 12
- Registration Number
- NCT02039765
- Locations
- 🇺🇸
Bausch & Lomb, Incorporated, Rochester, New York, United States
Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Phase 3
Completed
- Conditions
- InflammationPainCataract
- Interventions
- Drug: Vehicle (BID)Drug: Vehicle (TID)
- First Posted Date
- 2013-11-27
- Last Posted Date
- 2020-09-25
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 514
- Registration Number
- NCT01996839
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Bridgewater, New Jersey, United States
A Study to Evaluate a Mid Add Multi-Focal Soft Contact Lens
Not Applicable
Completed
- Conditions
- Presbyopia
- Interventions
- Device: LD127025 MFDevice: Air Optix Aqua MF
- First Posted Date
- 2013-10-09
- Last Posted Date
- 2020-09-30
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 146
- Registration Number
- NCT01959178
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States
Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness
Phase 3
Completed
- Conditions
- Hyperemia
- Interventions
- First Posted Date
- 2013-10-09
- Last Posted Date
- 2019-10-23
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 60
- Registration Number
- NCT01959230
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Memphis, Tennessee, United States
Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants
Phase 3
Completed
- Conditions
- Hyperemia
- Interventions
- First Posted Date
- 2013-10-09
- Last Posted Date
- 2019-10-23
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 507
- Registration Number
- NCT01959243
- Locations
- 🇺🇸
Bausch Site 3, Phoenix, Arizona, United States
🇺🇸Bausch Site 2, Philadelphia, Pennsylvania, United States
🇺🇸Bausch Site 1, Andover, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath